{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:51:57Z","timestamp":1784159517800,"version":"3.55.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.gastrohep.2019.09.012","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T18:08:19Z","timestamp":1576865299000},"page":"155-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Recomendaciones del Grupo Espa\u00f1ol de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las f\u00edstulas perianales de la enfermedad de Crohn"],"prefix":"10.1016","volume":"43","author":[{"given":"Marta M.","family":"Bosc\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Al\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Maroto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Nos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Hinojosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2019.09.012_bib0545","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","article-title":"The spectrum of perianal Crohn's disease in a population-based cohort","volume":"55","author":"Eglinton","year":"2012","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0550","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2019.09.012_bib0555","first-page":"P235","article-title":"Epidemiological study of perianal fistulas in patients with Crohn's disease","volume":"6","author":"Chaparro","year":"2012","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0560","series-title":"Manual pr\u00e1ctico. Conductas de actuaci\u00f3n en la enfermedad inflamatoria intestinal","article-title":"Tratamiento de la enfermedad perianal","author":"Al\u00f3s","year":"2014"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0565","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/BF02236633","article-title":"How can the assessment of fistula-inano be improved?","volume":"43","author":"Ratto","year":"2000","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0570","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0575","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gut.36.3.407","article-title":"Pelvic and perineal complications of Crohn's disease: Assessment using magnetic resonance imaging","volume":"36","author":"Haggett","year":"1995","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0580","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/MIB.0000000000000367","article-title":"Guidelines for imaging of Crohn's perianal fistulizing disease","volume":"21","author":"Ong","year":"2015","journal-title":"Infamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0585","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.crohns.2013.02.020","article-title":"Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus","volume":"7","author":"Panes","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0590","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2001.28676","article-title":"A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas","volume":"121","author":"Schwartz","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0595","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0600","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","article-title":"A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulizing Crohn's disease","volume":"63","author":"Gecse","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01889235","article-title":"Anal endosonography: Technique and normal anatomy","volume":"14","author":"Law","year":"1989","journal-title":"Gastrointest Radiol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0610","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10350-003-0015-8","article-title":"Ultrasound study of anal fistulas with hydrogen peroxide enhancement","volume":"47","author":"Navarro-Luna","year":"2004","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0615","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.3748\/wjg.v10.i19.2859","article-title":"Transcutaneous perianal sonography: A sensitive method for the detection of perianal inflammatory lesions in Crohn's disease","volume":"10","author":"Wedemeyer","year":"2004","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0620","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/014107687807100904","article-title":"Surgical pathology and management of anorectal Crohn's disease","volume":"71","author":"Hughes","year":"1978","journal-title":"J R Soc Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0625","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","article-title":"Usual therapy improves perianal Crohn's disease as measured by a new disease activity index","volume":"20","author":"Irvine","year":"1995","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0630","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"AGA technical review on perianal Crohn's disease","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bjs.1800630102","article-title":"A classification of fistula in ano","volume":"63","author":"Parks","year":"1976","journal-title":"Br J Surg."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0640","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2214\/ajr.171.2.9694464","article-title":"Outcome after surgery for perianal fistula: Predictive value of MR imaging","volume":"171","author":"Spencer","year":"1998","journal-title":"Am J Roentgenol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0645","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0650","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF02053756","article-title":"Clinical index to quantitate symptoms of perianal Crohn's disease","volume":"35","author":"Allan","year":"1992","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izy247","article-title":"Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease: The Toronto Consensus","volume":"25","author":"Steinhart","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0660","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.dld.2007.07.153","article-title":"Perianal Crohn's disease: Classification and clinical evaluation","volume":"39","author":"Vermeire","year":"2007","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0665","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncpgasthep0696","article-title":"Drug insight: Aminosalicylates for the treatment of IBD","volume":"4","author":"Nielsen","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0670","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/gut.7.2.181","article-title":"Corticosteroids and corticotrophin in the treatment of Crohn's disease","volume":"7","author":"Jones","year":"1966","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0675","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/00325481.2015.1023160","article-title":"Perianal Crohn's disease: A review","volume":"127","author":"Juncadella","year":"2015","journal-title":"Postgrad Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0680","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(80)90155-9","article-title":"Healing of perineal Crohn's disease with metronidazole","volume":"79","author":"Bernstein","year":"1980","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0685","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ibd.20608","article-title":"Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study","volume":"15","author":"Thia","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0690","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0695","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3892\/br.2014.368","article-title":"Meta-analysis of ciprofloxacin in treatment of Crohn's disease","volume":"3","author":"Wu","year":"2015","journal-title":"Biomed Rep."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0700","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","article-title":"Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease","volume":"18","author":"Dejaco","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0705","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","article-title":"Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: A double-blind placebo-controlled study","volume":"20","author":"West","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0710","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: A randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0715","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/MIB.0000000000000119","article-title":"Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease","volume":"20","author":"Kariyawasam","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0720","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0725","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF01318372","article-title":"Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease","volume":"30","author":"Korelitz","year":"1985","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0730","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0016-5085(91)90457-V","article-title":"Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease","volume":"101","author":"O\u2019Brien","year":"1991","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0735","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0016-5085(90)91160-8","article-title":"Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease","volume":"99","author":"Markowitz","year":"1990","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0740","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","article-title":"Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis","volume":"123","author":"Pearson","year":"1995","journal-title":"Ann Int Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0745","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000545.pub3","article-title":"Azathioprine and 6-mercaptopurine for induction of remission in Crohn's disease","author":"Prefontaine","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0750","first-page":"CD000545","article-title":"Azathioprine and 6-mercaptopurine for induction of remission in Crohn's disease","volume":"30","author":"Chande","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0755","first-page":"CD000297","article-title":"Cyclosporine for induction of remission in Crohn's disease","volume":"2","author":"McDonald","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0760","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2036.2011.04873.x","article-title":"Systematic review: The role of tacrolimus in the management of Crohn's disease","volume":"34","author":"McSharry K1","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0765","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0016-5085(03)00877-1","article-title":"Tacrolimus for the treatment of fistulas in patients with Crohn's disease: A randomized, placebo-controlled trial","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0770","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1053\/j.gastro.2004.01.046","article-title":"Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: Comments from Spanish experience","volume":"126","author":"Gonz\u00e1lez Lama","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0775","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00054725-199911000-00001","article-title":"Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae","volume":"5","author":"Lowry PW1","year":"1999","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0780","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajg.2011.73","article-title":"Efficacy of biological therapies in inflammatory bowel disease: Systemic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0785","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0790","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0795","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1542-3565(04)00414-8","article-title":"Long-term treatment of rectovaginal fistulas in Crohn's disease: Response to infliximab in the ACCENT II Study","volume":"2","author":"Sands","year":"2004","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0800","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.gastro.2005.01.048","article-title":"Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease","volume":"128","author":"Lichtenstein","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0805","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/j.1572-0241.2000.03366.x","article-title":"Clinical experience with infliximab therapy in 100 patients with Crohn's disease","volume":"95","author":"Farrell","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0810","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1572-0241.2001.03612.x","article-title":"Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: The first 100 patients","volume":"96","author":"Ricart","year":"2001","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0815","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0820","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1365-2036.2010.04466.x","article-title":"The CHOICE trial: Adalimumab demonstrates safety, fistula healing improved quality of life and increased work productivity in patients with Crohn's disease who failed prior to infliximab therapy","volume":"32","author":"Lichtiger","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0825","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0830","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn disease previously treated with infliximab: A randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0835","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2006.03232.x","article-title":"Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: A prospective, open-label, multicentre trial","volume":"25","author":"Hinojosa","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0840","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.crohns.2010.07.012","article-title":"Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure","volume":"4","author":"Echarri","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0845","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MCG.0000000000000169","article-title":"Effectiveness of adalimumab in perianal fistulas in Crohn's disease patients naive to anti-TNF therapy","volume":"49","author":"Casta\u00f1o-Milla","year":"2015","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0850","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","article-title":"Certolizumab pegol for the treatment of Crohn's disease","volume":"357","author":"Sandborn","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0855","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa062897","article-title":"Maintenance therapy with certolizumab pegol for Crohn's disease","volume":"357","author":"Schreiber","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0860","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2036.2010.04509.x","article-title":"Randomised clinical trial: Certolizumab pegol for fistulas in Crohn's disease \u2014 subgroup results from a placebo-controlled study","volume":"33","author":"Schreiber","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0865","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab","volume":"8","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0870","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0875","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-017-0842-x","article-title":"Pharmacological approach to the management of Crohn's disease patients with perianal disease","volume":"78","author":"Bermejo","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0885","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/ecco-jcc\/jjy019","article-title":"Efficacy of vedolizumab in fistulising Crohn's disease: Exploratory analyses of data from GEMINI 2","volume":"12","author":"Feagan","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0890","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2016.236","article-title":"The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: Results from the US VICTORY consortium","volume":"111","author":"Dulai","year":"2016","journal-title":"Am J Gastroenterol."},{"issue":"Suppl_1","key":"10.1016\/j.gastrohep.2019.09.012_bib0895","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/ecco-jcc\/jjx002.062","article-title":"Ef\ufb01cacy of vedolizumab on extraintestinal manifestation in patients with in\ufb02ammatory bowel disease: A post-hoc analysis of the OBSERV-IBD cohort from the GETAID","volume":"11","author":"Tadbiri","year":"2017","journal-title":"J Crohns Colitis."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2019.09.012_bib0900","doi-asserted-by":"crossref","first-page":"S077","DOI":"10.1093\/ecco-jcc\/jjy222.112","article-title":"DOP78 efficacy of vedolizumab in perianal Crohn's disease: The BioLAP multi-centre observational study","volume":"13","author":"Biron","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0905","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0016-5085(17)30930-7","article-title":"Fistula healing in pivotal studies of ustekinumab in Crohn's disease","volume":"152","author":"Sands","year":"2017","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0910","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn's disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0915","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn's disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0920","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/MIB.0000000000000842","article-title":"Ustekinumab for the treatment of refractory Crohn's disease: The Spanish experience in a large multicentre open-label cohort","volume":"22","author":"Khorrami","year":"2016","journal-title":"Inflamm Bowel Dis."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2019.09.012_bib0925","doi-asserted-by":"crossref","first-page":"S074","DOI":"10.1093\/ecco-jcc\/jjy222.108","article-title":"DOP74 efficacy of ustekinumab in perianal Crohn's disease: The BioLAP multi-centre observational study","volume":"13","author":"Biron","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0930","doi-asserted-by":"crossref","first-page":"O119","DOI":"10.1111\/codi.13286","article-title":"Systematic review of evidence and consensus on perianal fistula: An analysis of national and international guidelines","volume":"18","author":"De Groof","year":"2016","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0935","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ecco-jcc\/jjw039","article-title":"Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical aspects of perianal fistulising Crohn's disease-the unmet needs","volume":"10","author":"Gecse","year":"2016","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0940","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/codi.13462","article-title":"Surgical management of fistulating perianal Crohn's disease: A UK survey","volume":"19","author":"Lee","year":"2017","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0945","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrgastro.2017.104","article-title":"Perianal fistulizing Crohn's disease: Pathogenesis, diagnosis and therapy","volume":"14","author":"Pan\u00e9s","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0950","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/DCR.0b013e3181ce8b01","article-title":"Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano","volume":"53","author":"Soltani","year":"2010","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0955","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/BF02235371","article-title":"Cutaneous advancement flap closure: Alternative method for treatment of complicated anal fistulas","volume":"41","author":"Robertson","year":"1998","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0960","first-page":"1067","article-title":"Symptom amelioration in Crohn's perianal fistulas using video assisted anal fistula treatment (VAAFT)","volume":"12","author":"Adegbola","year":"2018","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0965","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10350-004-6611-4","article-title":"Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: A single center experience","volume":"46","author":"Topstad","year":"2003","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0970","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/MIB.0000000000001243","article-title":"Comparison of health care utilization and costs between patients with perianal fistulizing Crohn's disease treated with biologics with or without previous seton placement","volume":"23","author":"Schwartz","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0975","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/codi.13672","article-title":"Association of Coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn's disease","volume":"19","author":"Lee","year":"2017","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0980","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/00365521.2016.1205127","article-title":"The role of a defunctioning stoma for colonic and perianal Crohn's disease in the biological era","volume":"52","author":"Mart\u00ed-Gallostra","year":"2017","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0985","first-page":"113","article-title":"Surgical treatment of rectovaginal fistula in Crohn's disease: A tertiary center experience","volume":"30","author":"Milito","year":"2017","journal-title":"Surg Technol Int."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0990","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s13304-018-0558-9","article-title":"Gracilis muscle transposition for the treatment of recurrent rectovaginal and pouch-vaginal fistula: Is Crohn's disease a risk factor for failure? A prospective cohort study","volume":"70","author":"Rottoli","year":"2018","journal-title":"Updates Surg."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib0995","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s10350-004-7247-0","article-title":"A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula","volume":"45","author":"Lindsey","year":"2002","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1000","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10151-017-1739-0","article-title":"Efficacy of autologous fat graft injection in the treatment of anovaginal fistulas","volume":"22","author":"Norderval","year":"2018","journal-title":"Tech Coloproctol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10151-017-1599-7","article-title":"Five years of experience with the FiLaC\u2122 laser for fistula-in-ano management: Long-term follow-up from a single institution","volume":"21","author":"Wilhelm","year":"2017","journal-title":"Tech Coloproctol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1010","doi-asserted-by":"crossref","first-page":"A621","DOI":"10.1016\/S0016-5085(08)83091-0","article-title":"Healing of perianal fistulae by local injection of antibody to TNF","volume":"120","author":"Lichtiger","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10151-011-0759-4","article-title":"Local injection of infliximab in severe fistulating perianal Crohn's disease: An open uncontrolled study","volume":"15","author":"Alessandroni","year":"2011","journal-title":"Tech Coloproctol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/00365520600609941","article-title":"Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: A pilot study","volume":"41","author":"Asteria","year":"2006","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1025","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10350-004-0832-4","article-title":"Local injection of infliximab for the treatment of perianal Crohn's disease","volume":"48","author":"Poggioli","year":"2005","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1030","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/ibd.21210","article-title":"Local injection of adalimumab for perianal Crohn's disease: Better than infliximab?","volume":"16","author":"Poggioli","year":"2010","journal-title":"Inflamm Bowel Dis."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2019.09.012_bib1035","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1016\/S1873-9946(12)60412-7","article-title":"Combination of surgical therapy and local injections of adalimumab in treatment of complex perianal Crohn's disease","volume":"6","author":"Laureti","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1040","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/DCR.0b013e31825af532","article-title":"Effectiveness and safety of local adalimumab injection in patients with fistulizig perianal Crohn's disease: A pilot study","volume":"55","author":"Tonelli","year":"2012","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/eci.10.27","article-title":"Stem cell treatment for Crohn's disease","volume":"6","author":"Panes","year":"2010","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1050","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garcia-Olmo","year":"2005","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","article-title":"Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas","volume":"27","author":"Guadalajara","year":"2012","journal-title":"Int J Colorectal Dis."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1065","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1070","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004836-199410000-00006","article-title":"Hyperbaric oxygen for perianal Crohn's disease","volume":"19","author":"Lavy","year":"1994","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.09.012_bib1080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02054120","article-title":"Hyperbaric oxygenation in severe perineal Crohn's disease","volume":"38","author":"Colombel","year":"1995","journal-title":"Dis Colon Rectum"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570519302596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570519302596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:43:15Z","timestamp":1759322595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570519302596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0210570519302596"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2019.09.012","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones del Grupo Espa\u00f1ol de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las f\u00edstulas perianales de la enfermedad de Crohn","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}